Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T60226 |
CT52923
|
PDGFR | Angiogenesis; Tyrosine Kinase/Adaptors |
CT52923 is a selective, orally active antagonist of platelet-derived growth factor receptor (PDGFR), functioning as an ATP-competitive inhibitor. It has versatile applications for researching an array of pathological diseases such as atherosclerosis, glomerulonephritis, liver cirrhosis, pulmonary fibrosis, and cancer. |